Generic Products (September 2019)

Pharmacy Times, September 2019 Pain Management, Volume 85, Issue 9

Generic product news for September 2019

RAMELTEON TABLETSCOMPARE TO: Rozerem

Dr. Reddy's has launched its generic Rozerem in an 8-mg dosage strength indicated to treat insomnia. Frequent adverse effects include dizziness, drowsiness, and fatigue. The recommended dose of Ramelteon is 8 mg taken 30 minutes before going to bed and should not exceed 8 mg per day. The drug works by slowing down the nervous system, helping patients get to sleep faster and stay asleep.

DOSAGE FORM: Tablet

FOR MORE INFORMATION: drreddys.com

PREGABALIN CAPSULESCOMPARE TO: Lyrica

Amneal Pharmaceuticals recently received approval for and launched its generic version of Lyrica 25, 50, 75, 100, 150, 200, 225, and 300 mg. Pregabalin is indicated to treat neuropathic pain associated with diabetic peripheral neuropathy, fibromyalgia, postherpetic neuralgia, and spinal cord injury, as well as an adjunctive therapy to treat partial onset seizures in patients 17 years or older. Increased seizure frequency may occur if the drug is rapidly discontinued. The Amneal Pharmaceuticals FDA application was 1 of 9 approved in July for the first generics of Lyrica.

DOSAGE: Capsule

FOR MORE INFORMATION: amneal.com

ABIRATERONE ACETATE TABLETSCOMPARE TO: Zytiga

The FDA has approved MSN Labs' abiterone acetate 250-mg tablets to treat prostate cancer when used with a steroid medication (methylprednisolone or prednisone). The tablets are available in 120-count bottles to treat men with metastatic castration-resistant prostate cancer. Possible adverse effects include cough, headache, hot flush, hypertension, upper respiratory tract infection, and urinary tract infection.

DOSAGE: Tablet

FOR MORE INFORMATION: msnlabs.com

ERYTHROMYCIN DELAYED-RELEASE TABLETSCOMPARE TO: Ery-Tab

Amneal Pharmaceuticals has introduced erythromycin delayed-release tablets, the first generic of Arbor Pharmaceuticals' Ery-Tab. Erythromycin delayed-release tablets are indicated to treat infections caused by susceptible strains of designated microorganisms in a variety of diseases, including bronchitis, pertussis, and pneumonia. The drug works by stopping the growth of bacteria. The drug will be available in 250-, 333-, and 500-mg dosage strengths.

DOSAGE: Tablet

FOR MORE INFORMATION: amneal.com